173 related articles for article (PubMed ID: 37562180)
1. Safety of intravenous thrombolysis for ischemic stroke in patients with hematologic malignancies: A single institution experience.
Rael S; Webb M; Brown RD; Ruff MW; Keser Z; Sener U
J Stroke Cerebrovasc Dis; 2023 Sep; 32(9):107294. PubMed ID: 37562180
[TBL] [Abstract][Full Text] [Related]
2. Safety of Intravenous Thrombolysis among Stroke Patients Taking New Oral Anticoagulants--Case Series and Systematic Review of Reported Cases.
Shahjouei S; Tsivgoulis G; Bavarsad Shahripour R; Jones GM; Alexandrov AV; Zand R
J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2685-93. PubMed ID: 26542821
[TBL] [Abstract][Full Text] [Related]
3. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
Cheng JW; Zhang XJ; Cheng LS; Li GY; Zhang LJ; Ji KX; Zhao Q; Bai Y
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):381-390. PubMed ID: 29111341
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the safety and efficacy of intravenous thrombolysis for acute ischemic stroke patients with a history of intracerebral hemorrhage: a systematic review and meta-analysis.
Goh S; Tan NHW; Tan CH; Leow AST; Sia CH; Ho AFW; Lim MJR; Yeo LLL; Tan BYQ
J Thromb Thrombolysis; 2022 Feb; 53(2):485-494. PubMed ID: 34302590
[TBL] [Abstract][Full Text] [Related]
5. Predictive role of admission serum glucose, baseline NIHSS score, and fibrinogen on hemorrhagic transformation after intravenous thrombolysis with alteplase in acute ischemic stroke.
Huang P; Yi XY
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9710-9720. PubMed ID: 37916334
[TBL] [Abstract][Full Text] [Related]
6. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.
Masrur S; Abdullah AR; Smith EE; Hidalgo R; El-Ghandour A; Rordorf G; Schwamm LH
J Stroke Cerebrovasc Dis; 2011; 20(2):124-30. PubMed ID: 20598579
[TBL] [Abstract][Full Text] [Related]
7. Circadian Rhythm and Risk of Hemorrhagic Transformation after Acute Ischemic Stroke Treated with Intravenous Thrombolysis - A Systematic Review.
Stan A; Dragos H; Strilciuc S; Ilut S; Vacaras V; Cozma A; Panaitescu PS; Stan H; Muresanu DF
CNS Neurol Disord Drug Targets; 2023; 22(10):1493-1506. PubMed ID: 36200200
[TBL] [Abstract][Full Text] [Related]
8. Effect of intravenous thrombolysis in acute ischemic stroke patients with cerebral microbleeds and analysis of risk factors for hemorrhagic transformation.
Lei YS; Li H; Lei JY; Li SX; Li DF
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):779-786. PubMed ID: 35179744
[TBL] [Abstract][Full Text] [Related]
9. Recombinant tissue plasminogen activator (rTPA) management for first onset acute ischemic stroke with covid -19 and non-covid -19 patients.
Khedr EM; Abdelwarith A; Moussa G; Saber M
J Stroke Cerebrovasc Dis; 2023 Apr; 32(4):107031. PubMed ID: 36701854
[TBL] [Abstract][Full Text] [Related]
10. Outcome of multimodal MRI-guided intravenous thrombolysis in patients with stroke with unknown time of onset.
Zhao J; Zhao H; Li R; Li J; Liu C; Lv J; Li Y; Liu W; Ma D; Hao H; Xiao X; Liu J; Yin Y; Liu R; Yu Q; Wei Y; Li P; Wang Y; Wang R
Stroke Vasc Neurol; 2019 Mar; 4(1):3-7. PubMed ID: 31105972
[TBL] [Abstract][Full Text] [Related]
11. Low-dose intravenous recombinant tissue plasminogen activator in acute ischemic stroke without large vessel occlusion screened by 3T MRI.
Huynh QS; Tran CC; Nguyen-Thi HT; Nguyen TT; Phan-Thi HL; Luu-Dang DT; Le MT; Nguyen MD
Eur Rev Med Pharmacol Sci; 2023 Jul; 27(14):6554-6562. PubMed ID: 37522667
[TBL] [Abstract][Full Text] [Related]
12. Intravenous Thrombolysis in Acute Ischemic Stroke Patients with Unsuspected Infective Endocarditis.
Gopal M; Lakhani S; Lee VH
J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105502. PubMed ID: 33360518
[TBL] [Abstract][Full Text] [Related]
13. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
[TBL] [Abstract][Full Text] [Related]
14. Computed Tomography Angiography in Acute Stroke Patients Receiving Recombinant Tissue Plasminogen Activator: Outcome and Safety Evaluations in an Asian Population.
Lin CM; Wu HC; Wu YM; Liu CH; Chang KH; Chang TY; Huang KL; Chang YJ; Lee TH; Tsay PK; Cheng CK; Chang CH
Cerebrovasc Dis; 2020; 49(1):62-69. PubMed ID: 32023610
[TBL] [Abstract][Full Text] [Related]
15. Stroke Thrombolysis in Patients Taking Ticagrelor -Two Successful Cases and a Review of the Literature.
Landzberg DR; English S; Frankel M; Navalkele D
J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105520. PubMed ID: 33310594
[TBL] [Abstract][Full Text] [Related]
16. The safety and efficacy of tPA intravenous thrombolysis for treating acute ischemic stroke patients with a history of cerebral hemorrhage.
Zhao GJ; Wang ZR; Lin FZ; Cui YS; Xu SL
Braz J Med Biol Res; 2019 Jan; 52(2):e7739. PubMed ID: 30698226
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of intravenous thrombolysis with alteplase for treating acute ischemic stroke at different time windows: A protocol for systematic review and meta-analysis.
Huang B; Qian F; Fan X; Guan S; Zheng Y; Yang J; Xu F
Medicine (Baltimore); 2020 Dec; 99(52):e23620. PubMed ID: 33350738
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of intravenous r-tPA versus UK for acute ischaemic stroke: a nationwide prospective Chinese registry study.
Wang X; Li X; Xu Y; Li R; Yang Q; Zhao Y; Wang F; Sheng B; Wang R; Chen S; Wang L; Shen L; Hou X; Cui Y; Wang D; Peng B; Anderson CS; Chen H;
Stroke Vasc Neurol; 2021 Dec; 6(4):603-609. PubMed ID: 33903179
[TBL] [Abstract][Full Text] [Related]
19. Predictive model for the risk of hemorrhagic transformation after rt-PA intravenous thrombolysis in patients with acute ischemic stroke: A systematic review and meta-analysis.
Zhong K; An X; Kong Y; Chen Z
Clin Neurol Neurosurg; 2024 Apr; 239():108225. PubMed ID: 38479035
[TBL] [Abstract][Full Text] [Related]
20. Low- versus Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: An Updated Meta-Analysis.
Liu H; Zheng H; Cao Y; Pan Y; Wang D; Zhang R; You S; Zhang X; Li S; Tong X; Liu CF; Wang Y
J Stroke Cerebrovasc Dis; 2018 Apr; 27(4):988-997. PubMed ID: 29224744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
